You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Previously Untreated

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

Not yet recruiting
  • Follicular Lymphoma
  • Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Oct 30, 2023

Obinutuzumab-based Therapy for Previously Untreated FL

Recruiting
  • Follicular Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023

Peripheral T-cell Lymphoma Trial (Linperlisib in combination with CHOP)

Not yet recruiting
  • Peripheral T-cell Lymphoma
  • Linperlisib in combination with CHOP
  • (no location specified)
Jul 10, 2023

Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

Recruiting
  • Untreated Advanced Non-small Cell Lung Cancer
  • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Nov 13, 2023

Peripheral T Cell Lymphoma, Epigenetic Repression Trial in Tianjin (Chidamide, Azacitidine)

Recruiting
  • Peripheral T Cell Lymphoma
  • Epigenetic Repression
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 14, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Small Lymphocytic Lymphoma
  • (no location specified)
Jul 19, 2023

Mantle Cell Lymphoma Trial (Acalabrutinib, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • (no location specified)
Oct 31, 2022

Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

Not yet recruiting
  • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
    • (no location specified)
    Dec 16, 2022

    Previously Untreated Peripheral T-cell Lymphoma Trial in Tampa, Saint Louis, New York (CC-486 Administration, CHOP

    Active, not recruiting
    Has Results
    • Previously Untreated Peripheral T-cell Lymphoma
    • CC-486 Administration
    • CHOP Administration
    • Tampa, Florida
    • +3 more
    Jan 18, 2023

    Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

    Not yet recruiting
    • Untreated Advanced or Recurrent Thymic Carcinomas
    • Chuo, Tokyo, Japan
      National Cancer Center Hospital
    Apr 16, 2023

    Urothelial Carcinoma Trial (disitamab vedotin, pembrolizumab, gemcitabine)

    Not yet recruiting
    • Urothelial Carcinoma
    • disitamab vedotin
    • +4 more
    • (no location specified)
    Jun 9, 2023

    NSCLC Stage IV Trial in New York (Pembrolizumab, Radiation, Chemotherapy)

    Recruiting
    • NSCLC Stage IV
    • New York, New York
      NYU Langone Health
    Jan 11, 2023

    Breast Cancer Trial (RO7247669, Pembrolizumab, Nab-Paclitaxel)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    May 2, 2023

    Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

    Not yet recruiting
    • Large B-Cell Lymphoma
    • Xi'an, China
      First Affiliated Hospital of Medical College of Xi'an Jiaotong U
    Sep 14, 2023

    Advance NSCLC Trial (GFH925, Cetuximab)

    Not yet recruiting
    • Advance Non-small Cell Lung Cancer
    • (no location specified)
    Mar 7, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • (no location specified)
    May 29, 2023

    Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)

    Completed
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
    • +1 more
    Dec 5, 2022

    Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

    Completed
    • Lymphoid Leukemia
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin
    Jan 30, 2023

    Peripheral T-cell Lymphoma Targeted Therapy Trial in Tianjin (Azacitidine, Chidamide, Cyclophosphamide)

    Enrolling by invitation
    • Peripheral T-cell Lymphoma Targeted Therapy
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Insititute & Hospital
    Jan 9, 2023

    NSCLC Trial in Busan (GDC-6036, Pembrolizumab)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Busan, Korea, Republic of
      Pusan National University Hospital
    Apr 3, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jul 1, 2023

    Follicular Lymphoma (FL) Trial in Noblesville (Odronextamab, Rituximab, Cyclophosphamide)

    Recruiting
    • Follicular Lymphoma (FL)
    • Noblesville, Indiana
      Investigative Clinical Research of Indiana
    Oct 18, 2023

    NSCLC Stage IV Trial (HLX26, Serplulimab, Pemetrexed)

    Not yet recruiting
    • NSCLC Stage IV
    • (no location specified)
    Mar 15, 2023

    Severe Aplastic Anemia (SAA) Trial (Romiplostim, Antithymocyte Globulin, Cyclosporine A)

    Not yet recruiting
    • Severe Aplastic Anemia (SAA)
    • (no location specified)
    Sep 2, 2022